Ondine Biomedical

United States
Woodinville, Washington, Canada, 98072

Company profile

Ondine Biomedical company profile

Ondine Biomedical Inc. develops and commercializes innovative antimicrobial therapies using its patented photodisinfection technology to treat and prevent various infections, including healthcare-associated infections (HAIs).

Business identity

Contact email
[email protected]
Phone number
(604)669-0555
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
1997-01-01, Year

Headquarters

Postal code
98072
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
7
Total equity funding
$19.7M
Last funding
Post IPO Equity / $11.6M / 2024-11-01
Last equity funding
Post IPO Equity / $11.6M
Investors
1
Lead investors
1
Founders
1
Articles
79
Exited on
2021-12-06

Founders and investors

Founders

Carolyn Cross

Lead investors

TELUS Global Ventures

Investors

TELUS Global Ventures